NxStage Medical Inc. (NASDAQ:NXTM) President Joseph E. Turk, Jr. sold 12,169 shares of the business’s stock in a transaction dated Monday, November 28th. The stock was sold at an average price of $26.01, for a total value of $316,515.69. Following the sale, the president now directly owns 86,780 shares of the company’s stock, valued at $2,257,147.80. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink.

NxStage Medical Inc. (NASDAQ:NXTM) opened at 25.67 on Wednesday. NxStage Medical Inc. has a 12 month low of $13.49 and a 12 month high of $26.83. The company has a 50 day moving average price of $24.31 and a 200 day moving average price of $22.70. The firm’s market capitalization is $1.66 billion.

Insider Buying and Selling by Quarter for NxStage Medical (NASDAQ:NXTM)

COPYRIGHT VIOLATION NOTICE: “NxStage Medical Inc. (NXTM) President Joseph E. Turk, Jr. Sells 12,169 Shares” was originally posted by Daily Political and is the propert of of Daily Political. If you are viewing this article on another website, it was stolen and republished in violation of U.S. & international trademark & copyright legislation. The correct version of this article can be accessed at http://www.dailypolitical.com/2016/11/30/nxstage-medical-inc-nxtm-president-joseph-e-turk-jr-sells-12169-shares.html.

Several hedge funds have recently made changes to their positions in NXTM. Principal Financial Group Inc. raised its stake in shares of NxStage Medical by 1.1% in the third quarter. Principal Financial Group Inc. now owns 14,037 shares of the medical device company’s stock worth $351,000 after buying an additional 156 shares during the last quarter. Menta Capital LLC raised its stake in shares of NxStage Medical by 1.0% in the second quarter. Menta Capital LLC now owns 37,180 shares of the medical device company’s stock worth $806,000 after buying an additional 380 shares during the last quarter. State Board of Administration of Florida Retirement System raised its stake in shares of NxStage Medical by 1.3% in the second quarter. State Board of Administration of Florida Retirement System now owns 49,876 shares of the medical device company’s stock worth $1,081,000 after buying an additional 640 shares during the last quarter. BlackRock Advisors LLC raised its stake in shares of NxStage Medical by 1.5% in the second quarter. BlackRock Advisors LLC now owns 57,870 shares of the medical device company’s stock worth $1,255,000 after buying an additional 865 shares during the last quarter. Finally, Nationwide Fund Advisors raised its stake in shares of NxStage Medical by 2.4% in the second quarter. Nationwide Fund Advisors now owns 41,692 shares of the medical device company’s stock worth $904,000 after buying an additional 968 shares during the last quarter.

A number of analysts have recently commented on the company. Canaccord Genuity reaffirmed a “buy” rating and issued a $28.00 price target on shares of NxStage Medical in a research note on Thursday, November 3rd. Zacks Investment Research raised NxStage Medical from a “hold” rating to a “strong-buy” rating and set a $24.00 price target for the company in a research note on Thursday, November 3rd. Northland Securities set a $25.00 price target on NxStage Medical and gave the company a “buy” rating in a research note on Thursday, September 15th. BTIG Research reaffirmed a “buy” rating and issued a $29.00 price target on shares of NxStage Medical in a research note on Sunday, August 7th. Finally, Jefferies Group upped their price target on NxStage Medical from $24.00 to $27.00 and gave the company a “buy” rating in a research note on Friday, August 5th. One research analyst has rated the stock with a sell rating, six have issued a buy rating and one has assigned a strong buy rating to the company’s stock. NxStage Medical presently has a consensus rating of “Buy” and an average target price of $25.67.

NxStage Medical Company Profile

NxStage Medical, Inc is a medical technology company. The Company is engaged in the development, manufacturing and marketing of products and services for patients suffering from chronic or acute kidney failure. The Company operates through three segments: System One, In-Center and Services. It offers its products and services to various markets, such as home, critical care and in-center.

5 Day Chart for NASDAQ:NXTM

Receive News & Ratings for NxStage Medical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NxStage Medical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.